I

Innova Captab Ltd
NSE:INNOVACAP

Watchlist Manager
Innova Captab Ltd
NSE:INNOVACAP
Watchlist
Price: 975.4 INR -1.15%
Market Cap: 55.8B INR
Have any thoughts about
Innova Captab Ltd?
Write Note

Innova Captab Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Innova Captab Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
I
Innova Captab Ltd
NSE:INNOVACAP
Net Income (Common)
â‚ą943.5m
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Net Income (Common)
â‚ą16.7B
CAGR 3-Years
-7%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Net Income (Common)
-â‚ą1.5B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Net Income (Common)
-â‚ą1.7B
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Net Income (Common)
â‚ą4.8B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Vimta Labs Ltd
NSE:VIMTALABS
Net Income (Common)
â‚ą410.9m
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
14%
No Stocks Found

Innova Captab Ltd
Glance View

Market Cap
55.8B INR
Industry
Life Sciences Tools & Services

Innova Captab Ltd is a IN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Panchkula, Haryana. The company went IPO on 2023-12-29. Innova Captab Ltd is an integrated pharmaceutical company. The firm is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company has presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes CDMO business, domestic branded generics business, and international branded generic product business. Its CDMO business provides research, product development and manufacturing services. Its branded generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. The company has developed a diversified branded generics product portfolio including Tablets, capsules, dry syrups, dry powder injection, ointments and liquid orals.

INNOVACAP Intrinsic Value
813.53 INR
Overvaluation 17%
Intrinsic Value
Price
I

See Also

What is Innova Captab Ltd's Net Income (Common)?
Net Income (Common)
943.5m INR

Based on the financial report for Mar 31, 2024, Innova Captab Ltd's Net Income (Common) amounts to 943.5m INR.

What is Innova Captab Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
40%

Over the last year, the Net Income (Common) growth was 39%. The average annual Net Income (Common) growth rates for Innova Captab Ltd have been 40% over the past three years .

Back to Top